JNJ241227P126000
- 0.00
- 0.000.00%
Johnson & Johnson Newsroom
Sector Update: Health Care Stocks Edge Up in Afternoon Trading
FDA Proposes Testing Talc Products for Asbestos: Report
Johnson & Johnson Signs Licensing Deal for Kaken's Program for Autoimmune, Allergic Diseases
Johnson & Johnson (JNJ) Is Attracting Investor Attention: Here Is What You Should Know
Express News | J&J: Kaken Eligible to Get Equity Investment From Johnson & Johnson Innovation – Jjdc, Inc.
Express News | J&J: Gains Exclusive License to Kaken’s Stat6 Inhibitor Program, Including Lead Candidate Kp-723
Express News | J&J: To License Novel Oral Assets, Further Strengthening Commitment to Atopic Dermatitis
Top 7 Blue-Chip Stocks With The Best Return Potential Going Into 2025
Why the 'Dogs of the Dow' Stocks Just Might Deliver in 2025
RxSight Cut to Hold at Stifel on Competition Concerns
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
After GE's Spinoff Success, What's Next for Honeywell, FedEx
Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services
Why Is Johnson & Johnson (JNJ) Among the Best Dividend Stocks to Invest In?
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Express News | FOMC Cuts Interest Rates by 25 Basis Points, Sees Fewer Reductions Next Year
Dow's Drop: How Blue-chips Have Fared During Index's Peak Turned Worst-run in Decades
Dow Breaks Downward Spiral, with FOMC Rate Cut on Deck | Live Stock
Least Shorted S&P 500 Stocks in November
Dow on a Record Losing Streak: Should You Buy Its ETF?